SUPPLEMENT PROTOCOL - AN OVERVIEW

below equally Drake’s and Lynch’s products, the expense of deleterious mutations is exactly what drives mutation fees down (Drake 1991; Lynch 2010; Sung et al. 2012). consequently, below both types, an increase in the common cost of mutations would cause a decrease in mutation rates. To examine this, Drake examined mutation prices of thermophil